You are here

  • Home
  • Archive
  • Volume 9, Issue 1
  • Predictors of treatment response in a lupus nephritis population: lessons from the Aspreva Lupus Management Study (ALMS) trial

Article metrics

Article menu
Biomarker studies
Original research
Predictors of treatment response in a lupus nephritis population: lessons from the Aspreva Lupus Management Study (ALMS) trial

 

Online download statistics by month:

Online download statistics by month: May 2022 to September 2024

AbstractFullPdf
May 202214914712
Jun 2022686694197
Jul 2022317316122
Aug 202227027287
Sep 202217017377
Oct 202215815253
Nov 202212512457
Dec 202210510448
Jan 202310410143
Feb 202313011354
Mar 2023898555
Apr 2023777548
May 2023918553
Jun 202311110549
Jul 2023626039
Aug 2023716620
Sep 2023494721
Oct 2023464023
Nov 2023706423
Dec 2023695522
Jan 2024414119
Feb 2024414120
Mar 2024535158
Apr 2024646447
May 2024737037
Jun 2024736845
Jul 2024928374
Aug 2024625351
Sep 2024504949
Total349833981503